Davis R M Inc. Sells 3,959 Shares of STERIS plc $STE

Davis R M Inc. decreased its holdings in STERIS plc (NYSE:STE) by 62.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,418 shares of the medical equipment provider’s stock after selling 3,959 shares during the quarter. Davis R M Inc.’s holdings in STERIS were worth $598,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Steigerwald Gordon & Koch Inc. purchased a new position in shares of STERIS during the 3rd quarter worth $25,000. Spurstone Advisory Services LLC bought a new position in STERIS in the 2nd quarter worth $29,000. Cloud Capital Management LLC purchased a new position in STERIS during the third quarter valued at $29,000. Geneos Wealth Management Inc. grew its holdings in STERIS by 416.0% during the first quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 104 shares during the period. Finally, TruNorth Capital Management LLC bought a new stake in STERIS during the third quarter valued at about $37,000. 94.69% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research firms have recently weighed in on STE. Weiss Ratings reaffirmed a “buy (b)” rating on shares of STERIS in a research report on Friday, January 9th. Wall Street Zen cut shares of STERIS from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 14th. Six research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, STERIS currently has an average rating of “Moderate Buy” and an average price target of $275.20.

STERIS Stock Down 1.8%

NYSE STE opened at $247.73 on Tuesday. STERIS plc has a 12 month low of $204.90 and a 12 month high of $269.44. The company has a current ratio of 2.48, a quick ratio of 1.75 and a debt-to-equity ratio of 0.26. The stock has a market cap of $24.29 billion, a PE ratio of 34.55 and a beta of 1.05. The stock’s 50 day moving average is $255.69 and its 200 day moving average is $251.78.

STERIS (NYSE:STE) last announced its quarterly earnings data on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.53. STERIS had a net margin of 12.15% and a return on equity of 14.34%. The business’s revenue was up 9.2% on a year-over-year basis. During the same quarter last year, the company posted $2.32 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. Research analysts predict that STERIS plc will post 9.08 EPS for the current fiscal year.

STERIS Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Tuesday, February 17th will be issued a $0.63 dividend. This represents a $2.52 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Tuesday, February 17th. STERIS’s payout ratio is 35.15%.

STERIS Profile

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.